Industry Educational Session - The time has come to change SCD and TDT care. Promotional symposium- Sponsored by Vertex
Tracks
-
| Sunday, April 27, 2025 |
| 12:35 PM - 1:20 PM |
| Carron 2 |
Details
Discover how far we’ve come after years of limited treatment options for sickle cell disease (SCD) and transfusion-dependent ß-thalassaemia (TDT). Dr Nandini Sadasivam, Dr Farhan Anjum and Dr Kate Gardner will share real-world insights and the latest updates as we enter this exciting new era of medicine.
The session will conclude with a panel discussion and an opportunity to ask questions.
This promotional symposium is sponsored by Vertex Pharmaceuticals and intended for UK healthcare professionals only. Vertex Pharmaceuticals products will be discussed in this symposium. Prescribing and adverse event reporting information will be available at the meeting.
GB-72-2500016 | April 2025
Speaker
Farhan Anjum
Consultant Manchester Foundation Trust
- Consultant Haematologist at Manchester University NHS Foundation
Dr Kate Gardner
Consultant Haematologist
Guy's And St Thomas' NHS Foundation Trust
-Chair of the National Haemoglobinopathy Panel (NHP) Trust and Consultant Haematologist at Guy’s and St Thomas’ NHS Foundation Trust
Dr. Nandini Sadasivam
Consultant
Manchester Foundation Trust
- Consultant Haematologist and Haemoglobinopathy Coordinating Centre (HCC) Clinical Lead for Thalassaemia & Rare Inherited Anaemia at Manchester University NHS Foundation Trust
